Why non-mydriatic cameras will not replace dilated fundus exams

Article

The sensitivity and specificity of digital photography techniques - including non-mydriatic photography - are not as high as those of traditional fundus evaluation.

Baltimore-The sensitivity and specificity of digital photography techniques-including non-mydriatic photography-are not as high as those of traditional fundus evaluation. Nevertheless, these techniques may be useful in the future for screening and treatment trials, said Mahsa Salehi, OD, FAAO, here at the 5th annual Evidence Based Care in Optometry conference.

The AOA guidelines "mention that fundus photography provides documentation and is the best routine approach to establish a baseline for routine comparisons," she said. "They further point out that fundus photography is a more reproducible technique than the clinical exam for detecting posterior segment disease. It is not, however, medically necessary to document the existence of a condition, but medically necessary to establish the baseline to judge later if a disease is progressive." However, she noted that most third-party payers will not cover retinal photography alone without a concurrent eye examination.

Diabetic retinopathy (DR) continues to be one of the leading causes of blindness in the United States despite highly effective treatments. "We need to improve our ability to detect the onset of vision-threatening diabetic retinopathy by increasing our rates of screening of persons with diabetes," Dr. Salehi said, "especially for countries or areas that are not privileged and do not have as much access to ophthalmic care."

The gold standard for the documentation of DR consists of color-film stereoscopic photography of the seven standard fields, as the Early Treatment of Diabetic Retinopathy Study (ETDRS) established. "Photo screening, however, will not always detect the subtle signs and changes of DR, such as retinal thickening, but a success rate of 80% to 92% in detecting DR is claimed by researchers," Dr. Salehi noted.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.